HomeTagsPrecision oncology

Tag: precision oncology

Healthcare

Tempus AI to Acquire Personalis in $1.5 Billion Deal to Deepen Integration of AI-Powered Molecular Residual Disease Testing

Tempus AI, Inc., a leader in precision medicine, has signed a definitive deal for the acquisition of Personalis, Inc. The deal, worth an enterprise...

Healthcare

The Caris Precision Oncology Alliance Welcomes Leading Cancer Center

Caris expands its extensive network of leading cancer institutions committed to improving patient outcomes through innovations in precision medicine by welcoming Mass General Cancer...

Healthcare

New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance

Veracyte, Inc., a leading cancer diagnostics company, announced that a new study published in JCO Precision Oncology shows that, among patients undergoing Active Surveillance (AS)...

Healthcare

Precision Oncology Innovator SimBioSys and General Inception Announce Strategic Partnership to Accelerate Cancer Drug Development

PhenoScope can cut drug development time and costs significantly, while delivering safer & more effective therapy for cancer patients SimBioSys, a leading innovator in precision...

Healthcare

New Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening Gap

Guardant Health, Inc., a leading precision oncology company, announced the results of a new survey showing patients and physicians overwhelmingly agree that blood-based testing...

Healthcare

Certis Oncology Named ‘Overall Immunology Company of the Year’ in 2023 BioTech Breakthrough Awards

Certis Oncology Solutions (Certis), a translational science and precision oncology company, announced it has been selected as "Overall Immunology Company of the Year" in...

Tag: precision oncology

Recent Published

About Us

Latest

Popular

Quick Link